Welcome to
Together is a new resource for anyone affected by pediatric cancer - patients and their parents, family members, and friends.
Learn MoreOther names: Pineal gland tumor, Pinealoblastoma
Pineoblastoma is a very rare brain tumor that develops in the pineal gland. The pineal gland is a tiny structure found deep within the brain. The main pineal gland function is to release melatonin, a hormone that controls sleep.
Pineoblastoma is a rare tumor that develops in the pineal gland in the brain. The pineal gland releases melatonin, a hormone that controls sleep.
Pineoblastoma is most common in children and young adults. However, it is a rare tumor. Pineoblastomas account for less than 1% of childhood brain tumors. About half of tumors that occur in the pineal gland are pineoblastomas. Other tumors that can occur in the pineal gland include germ cell tumors, gliomas, and benign pineal parenchymal tumors.
Pineoblastomas are usually treated with surgery, radiation therapy, and chemotherapy. Because of the location of the tumor, pineoblastoma can be hard to treat. The 5-year survival rate for childhood pineoblastoma is about 60-65%.
Signs and symptoms of pineoblastoma depend on the tumor size and spread to other parts of the brain. Often, the tumor causes cerebrospinal fluid to build up (hydrocephalus) and puts pressure on the brain.
Pineoblastoma symptoms may include:
The brain has a connected set of fluid-filled openings, called ventricles. As a pineal gland tumor grows, it can press on one of these chambers and block the normal flow of cerebrospinal fluid. This causes a buildup of fluid within the brain known as hydrocephalus. The fluid increases pressure on the brain (intracranial pressure). Many of the symptoms of pineal tumors are due to the increased pressure against brain tissue.
Doctors test for pineoblastoma in several ways.
MRI scan with markings showing pineoblastoma. About half of pineal gland tumors are pineoblastomas.
There is no standard staging for pineoblastoma. However, doctors may classify the tumor by spread of disease. Pineoblastoma may spread through the cerebrospinal fluid in 10-20% of cases. It rarely spreads to other parts of the body outside the central nervous system.
Pineal gland tumors are classified by how they look under the microscope. The more abnormal tumor cells look, the higher the grade. Pineoblastomas are high-grade (grade IV) tumors.
Pineoblastomas are very similar in histology to medulloblastoma.
Successful removal of the tumor and treatment with radiation therapy are associated with better outcomes for children with pineoblastoma.
Factors that affect chance of cure include:
Survival rates for newly diagnosed pineoblastoma are about 60-65%.
Treatment for pineoblastoma depends on several factors including the size and location of the tumor and the child’s age. The main treatments for pineoblastoma are surgery, radiation therapy, and chemotherapy. Treatment plans are often similar to those used for medulloblastoma. Patients may be eligible for treatment through a clinical trial.
Surgery is used to remove as much of the tumor as possible. Surgery for pineoblastoma can be complex because of the tumor location and the risk to nearby blood vessels.
Some patients with pineoblastoma may have surgery to help manage hydrocephalus. This may include creating an opening in the floor of the third ventricle in the brain (third ventriculostomy) to keep fluid from building up. In other cases, doctors may place a shunt, a small tube that drains cerebrospinal fluid (CSF) so that the fluid can be removed from the brain. The shunt may be temporary or permanent.
Some patients with pineoblastoma will have surgery to place a shunt to prevent hydrocephalus. A shunt is a small tube that drains cerebrospinal fluid so it can be removed from the brain.
Radiation therapy is often used after surgery for pineoblastoma. The dose and extent of radiation therapy depends on patient risk factors, whether the disease has spread, and patient age. Radiation is not used in very young children due to the increased risk of long-term side effects. In general, for patients older than 3 years of age, radiation is delivered over the entire central nervous system (craniospinal irradiation) with a higher dose (boost) at the primary tumor site. Late effects due to radiation can potentially occur and need to be monitored.
Radiation therapy may be used to treat pineoblastoma. This therapy uses beams of radiation to shrink tumors and kill cancer cells by damaging the DNA inside cancer cells.
Ongoing follow-up care, laboratory tests, and routine MRI scans are used to monitor patients after completion of treatment. Monitoring should focus on early detection of recurrence and treatment for potential neurological, cognitive, and endocrine complications.
Patients who receive radiation therapy to the pineal gland are at risk for long-term endocrine problems including pituitary gland dysfunction (hypopituitarism). Low pituitary function can lead to problems such as delayed growth, fatigue, and fertility problems. Ongoing monitoring of hormone levels is important, and patients may need medicines including hormone replacement.
Patients who receive radiation therapy to the pineal gland are at risk for long-term endocrine system changes that may lead lead to problems such as delayed growth, fatigue, and fertility problems.
Regular checkups and screenings by a primary care physician are important to watch for health problems or late effects of treatment that can develop years after therapy.
—
Reviewed: January 2020
